or Try an Advanced Search...

    Technical Analysis for NRX - NurExone Biologic Inc

    Grade Last Price % Change Price Change
    C 0.610 -3.17% -0.020
    NRX closed down 3.17 percent on Friday, July 26, 2024, on 1.2 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Flat Down
    Historical NRX trend table...
    Date Alert Name Type % Chg
    Stochastic Reached Oversold Weakness 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    1,2,3 Pullback Bullish Bullish Swing Setup -3.17%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.17%
    Down 3 Days in a Row Weakness -3.17%
    Gapped Down Weakness -3.17%
    Lower Bollinger Band Touch Weakness -3.17%
    Fell Below 20 DMA Bearish -8.96%
    Older End-of-Day Signals for NRX ...

       Recent Intraday Alerts

    Alert Time
    Down 3% about 8 hours ago
    Down 2% about 8 hours ago
    Down 1% about 8 hours ago
    Fell Below Lower Bollinger Band about 8 hours ago
    Non-ADX 1,2,3,4 Pullback Entry about 12 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    NRX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    NurExone Biologic Inc., a pharmaceutical company, engages in the development of novel, biologic, and minimal-invasive treatment for the spinal cord and traumatic brain injury. It develops a biological extracellular vesicles-based technology drug platform to treat damage in the central nerve system. The company was founded in 2020 and is based in Toronto, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical

    Is NRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 17 Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma
    Jul 17 Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
    Jul 5 Updates from NurExone: Growth Conference Presentation and Website Relaunch
    Jun 28 NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
    Jun 21 On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
    Jun 11 NurExone Announces Expansion of ExoPTEN Patent Coverage with Notice of Allowance for Japanese Patent Application
    Jun 4 NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders
    May 31 Is NurExone Biologic (CVE:NRX) In A Good Position To Deliver On Growth Plans?
    May 29 NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials
    May 17 NurExone Welcomes Biopharma Exec Dr. Ram Petter to Drive Strategic Collaborations
    See more NRX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.19
    52 Week Low 0.1
    Average Volume 82,926
    200-Day Moving Average 0.502
    50-Day Moving Average 0.610
    20-Day Moving Average 0.684
    10-Day Moving Average 0.684
    Average True Range 0.044
    RSI (14) 43.18
    ADX 29.97
    +DI 32.667
    -DI 29.203
    Chandelier Exit (Long, 3 ATRs) 0.638
    Chandelier Exit (Short, 3 ATRs) 0.742
    Upper Bollinger Bands 0.758
    Lower Bollinger Band 0.609
    Percent B (%b) 0.01
    BandWidth 21.829
    MACD Line 0.007
    MACD Signal Line 0.019
    MACD Histogram -0.012
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.670
    Resistance 3 (R3) 0.677 0.663 0.660
    Resistance 2 (R2) 0.663 0.648 0.660 0.657
    Resistance 1 (R1) 0.637 0.639 0.630 0.630 0.653
    Pivot Point 0.623 0.623 0.620 0.620 0.623
    Support 1 (S1) 0.597 0.608 0.590 0.590 0.567
    Support 2 (S2) 0.583 0.599 0.580 0.563
    Support 3 (S3) 0.557 0.583 0.560
    Support 4 (S4) 0.550